FDA Guidance Clarifies Agency Regs v. Revised Common Rule

The FDA released new guidance on how researchers can comply with both agency regulations and pending Common Rule revisions that protect human subjects in clinical trials.
Source: International Pharmaceutical Regulatory Monitor